News

Filter

Current filters:

None

7951 to 7960 of 97511 results

Bayer attempts to block generic Nexavar in India again slammed by MSF

04-09-2012

German drug major Bayer (BAYN: DE) yesterday headed to India's Intellectual Property Appellate Board…

Asia-PacificBayerGenericsLegalNexavarOncologyPatentsPharmaceutical

Boehringer reveals new data on olodaterol and tiotropium combo at ERS

04-09-2012

German family-owned drug major Boehringer Ingelheim for the first time presented data from a Phase II…

Boehringer IngelheimolodaterolPharmaceuticalResearchRespiratory and PulmonarySpirivatiotropium

Almirall says Eklira Genuair provides meaningful and sustained bronchodilation from the first dose

04-09-2012

Spain's largest drugmaker, Almirall (ALM: MC) yesterday announced positive results for two Phase IIIb…

AlmirallEklira GenuairPharmaceuticalResearchRespiratory and Pulmonary

Galapagos unit in CNS discovery deal with Ono Pharma

03-09-2012

Belgian biotech firm Galapagos NV (Euronext: GLPG) says that its service division BioFocus and Japanese…

BioFocusBiotechnologyGalapagosNeurologicalOno PharmaceuticalPharmaceuticalResearch

New data from Novartis on QVA149 and Seebri Breezhaler at ERS

03-09-2012

Further data from the once-daily chronic obstructive pulmonary disease (COPD) clinical trial programs…

NovartisPharmaceuticalQVA149ResearchRespiratory and PulmonarySeebri BreezhalerVectura

Mitsubishi Tanabe to take full control of Bipha JV

03-09-2012

Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has agreed to acquire the 49% holding (20,580…

Bipha CorpMergers & AcquisitionsMitsubishi TanabePharmaceutical

Merck Serono creates second company under EPP

03-09-2012

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), has established Quartz Bio, the second spin-off…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalQuartz Bio

Taiwan's health care market boosted by aging population

03-09-2012

Although a challenge for the national government, a growing aging population combined with the country's…

Asia-PacificGenericsHealthcareMarkets & MarketingPharmaceutical

FDA backs Medivation and Astellas' prostate cancer drug Xtandi

03-09-2012

USA-based Medivation (Nasdaq: MDVN and Japanese drug major Astellas Pharma (TYO: 4503) say that the US…

Astellas PharmaBiotechnologyenzalutamideMedivationNorth AmericaOncologyPharmaceuticalRegulationXtandi

7951 to 7960 of 97511 results

Back to top